Buffl

Baumeister DNA/RNA Genetics / Epigenetics

JP
by Julius P.

The protein Cas9 from the bacterium Thermus thermophilus belongs to type III Cas systems and cleaves single-stranded RNA (instead of double-stranded DNA), but otherwise functions very similar to DNA-cleaving Cas9. You want to express this Cas9 from genomic DNA of Thermus thermophilus to express it in the nematode C. elegans to allow cleavage (and, thus, destruction) of the mRNA of daf-2, exclusively in the intestine.

a. Describe a standard method to allow expression of Tth Cas9 in C. elegans intestinal cells.

b. What, in addition to the expression of Cas9, do you also need to do in order to get this CRISPR/Cas9 system working in the worm?

c. How do you monitor efficacy of this Cas9 function in the worm?

a. Expression of Tth Cas9 in C. elegans Intestinal Cells:

  • Promoter Selection: Choose a tissue-specific promoter that is active in the intestine of C. elegans. The intestine-specific promoter could be derived from a gene known to be expressed exclusively or predominantly in the intestinal cells, such as the promoter of the vha-6 gene.

  • Cloning: Clone the Tth Cas9 coding sequence downstream of the selected intestine-specific promoter in a suitable vector for expression in C. elegans. Include transcriptional and translational regulatory elements for efficient expression.

  • Transformation: Introduce the plasmid containing the Cas9 expression construct into C. elegans intestinal cells using microinjection or other established methods for genetic transformation.

b. Additional Steps for CRISPR/Cas9 System:

  • sgRNA Design: Design a single-guide RNA (sgRNA) specific to the target mRNA sequence of daf-2. The sgRNA guides Cas9 to the target site, allowing the RNA cleavage to occur.

  • sgRNA Expression: Express the sgRNA under the control of a suitable promoter. Often, a U6 promoter or other RNA polymerase III promoters are used for sgRNA expression.

  • Co-Transformation: Co-transform C. elegans with both the Cas9 expression construct and the sgRNA expression construct.

c. Monitoring Efficacy of Cas9 Function:

  • Phenotypic Analysis: Monitor for phenotypic changes associated with the disruption of daf-2 mRNA. In the case of daf-2, this could include observing alterations in the dauer formation or other phenotypes related to the insulin/IGF-1 signaling pathway.

  • Molecular Analysis: Perform molecular assays, such as RT-qPCR, to quantify the expression levels of the daf-2 mRNA. A decrease in daf-2 mRNA levels would indicate the efficacy of the Cas9-mediated RNA cleavage.

  • GFP Reporter System: Introduce a GFP reporter system downstream of the daf-2 promoter. If the Cas9-mediated cleavage is successful, it should result in the loss or reduction of GFP expression, serving as an indirect indicator of Cas9 activity.


A genetic cross is being performed between C. elegans mutants daf-2 and daf-16. The phenotypic characteristics of each mutant are displayed below. daf-2 is localized on chromosome III, daf-16 is localized on chromosome I. The F1 generation of this cross is phenotypically inconspicuous (no phenotypic differences from wild type can be observed).

a. How do you interprete this result with respect to the genetic characteristics of the mutants involved?

b. Describe the genotypes you expect to get in the F1 generation progeny of this cross.

c. The F2 generation phenotypes are a mixture of: - wild type animals - dauer-constitutive animals - dauer-defective animals You will isolate 100 progeny of the F2 generation. Which segregation (representation by percentage) of phenotypes do you expect to get among the F2 animals?

d. In an alternative cross of two mutants, unc-2 and daf-16, you receive, in addition to Unc and Daf-d mutants, also Unc Daf-d double mutants. Describe why you do not receive F2 generation progeny with a Daf-c and Daf-d double mutant phenotype in the daf-2 x daf-16 cross. Please provide a genetic interpretation of this effect.

a. Interpretation of the Result: The inconspicuous phenotype in the F1 generation suggests that there is complementation between the daf-2 [Daf-c (dauer constitutive)] and daf-16 [Daf-d (dauer-defective)] mutations. Complementation occurs when mutations in different genes (in this case, daf-2 and daf-16) restore the wild-type phenotype when present together in the same organism. This could imply that the mutations in daf-2 and daf-16 affect different steps or components within the same pathway, or that they are in genes functioning in parallel or converging pathways.

b. Expected Genotypes in the F1 Generation: Assuming complementation, the F1 generation would be heterozygous for both daf-2 and daf-16 mutations. The genotypes of the F1 progeny would be DdFf, where D represents the wild-type allele (in table +), d represents the daf-2 mutation, F represents the wild-type allele of daf-16 (in table +), and f represents the daf-16 mutation.

c) Segregation of Phenotypes in the F2 Generation:

  • Wild type animals (DdFf): Approximately 9/16 or 56.25%

  • Dauer-constitutive animals (ddFf or Ddff): Approximately 3/16 or 18.75%

  • Dauer-defective animals: Approximately 4/16 or 25% !the epistatic double mutant included

d) The daf-2 mutation likely results in a Daf-c phenotype, and the daf-16 mutation results in a Daf-d phenotype. In the double mutant (Daf-c Daf-d), the two mutations might be epistatic to each other, meaning that the presence of one mutation masks the effect of the other. (the two mutated genes are non allelic) —> the dauer defective mutant might dominate?

Important aspects in regulation of translation.

  • Antibiotic binding the ribosome subunits: tetracycline, spectinomycin …


  • Initiation Factors: The initiation phase is a critical regulatory point in translation. Initiation factors, such as eIF4E, eIF4G, and eIF2, play essential roles in recruiting the ribosome to the mRNA, positioning it correctly, and ensuring the proper start of translation. Various signaling pathways, including the mTOR (=translation active)pathway, can influence the activity of initiation factors.

  • mRNA Cap Structure: The 5' cap structure of mRNA is essential for translation initiation. The cap-binding complex, eIF4E (4E binding protein blocks translation in heat shock by dephosphorylation of 4E-BP), recognizes and binds to the cap, facilitating the recruitment of the small ribosomal subunit and the initiation of translation.

  • RNA Secondary Structures and UTRs: The untranslated regions (UTRs) of mRNA, particularly the 5' and 3' UTRs, can contain regulatory elements that influence translation. Secondary structures in these regions may impede or facilitate the binding of translation initiation factors, affecting the efficiency of translation.

  • RNA-Binding Proteins (RBPs): RBPs interact with mRNA molecules (or other way around) and can either promote or inhibit translation. For example, some RBPs bind to the 3' UTR and regulate translation by influencing mRNA stability, localization, or the accessibility of the mRNA to the translation machinery. —> characterizetion by cross-linking (protein to RNA), digestion, immuno precipitation (collect the proteins = antibody specific), analyse by high throughput sequencing (+ separating by SDS), alternative RNA Affinity Chromatography = RNA immobalized to catch the RBPs or mass spectrometry

  • MicroRNAs (miRNAs) and Small Interfering RNAs (siRNAs): These small RNA molecules can post-transcriptionally regulate gene expression by binding to specific mRNA sequences. When miRNAs bind to the 3' UTR of target mRNAs, they often repress translation or promote mRNA degradation.

  • Initiation Codon Context: The nucleotide sequence surrounding the initiation codon (AUG) can influence the efficiency of translation initiation. Certain sequence features, such as the Kozak consensus sequence, can enhance or inhibit translation initiation at specific start codons.

  • RNA Modifications: Post-transcriptional modifications, such as m6A (N6-methyladenosine) methylation, can affect mRNA stability and translation efficiency. The dynamic regulation of these modifications contributes to the fine-tuning of gene expression.

  • Regulation by Cellular Signaling Pathways: Various cellular signaling pathways, including those involving kinases and phosphatases, can impact translation. For example, the mTOR pathway is a central regulator of translation initiation, integrating signals from nutrient availability, energy status, and growth factors. Regulation of eIF2(b) by GDP bound = inactivation and activated by GEF exchanging GDP to GTP

  • Stress Response and Integrated Stress Response (ISR): Cellular stress conditions, such as endoplasmic reticulum (ER) stress or amino acid deprivation, can activate the integrated stress response. This response involves the phosphorylation of eIF2α, leading to global translational repression while allowing the preferential translation of stress-response genes.

  • Translation repressors (repressor proteins that bind and block)

  • RNA thermosensors (RNA structure opens with increased temperature —> listeria virulence genes)

  • small molecules that change RNA secondary structure (S-adenosyl methionin [SAM] blocks synthesis of its own production enzymes)

  • antisense RNAi that bind the mRNA (opposite strand -base pairing) and blocks translation, experiments in C. elegans showed that insertion of double strand RNA was more effective to produce interference (because of DICER —> dsRNA cutter to make siRNAs and RISC / Argonaut proteinfamily —> using the siRNAs as guides to cleave the target mRNAs


Author

Julius P.

Information

Last changed